Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

Benzinga Newsdesk www.benzinga.com Negative 60.4%

Neg 60.4% Neu 0% Pos 0%

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $81 to $80.